Related references
Note: Only part of the references are listed.MicroRNA regulates human vitamin D receptor
Takuya Mohri et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b
Sayaka Komagata et al.
MOLECULAR PHARMACOLOGY (2009)
Mammary Epithelial Cell Transformation Is Associated With Deregulation of the Vitamin D Pathway
Carly M. Kemmis et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
The vitamin D receptor in cancer
James Thorne et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
CYP27A1 and CYP24 expression as a function of malignant transformation in the colon
Damien Matusiak et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Estimates of the cancer incidence and mortality in Europe in 2006
J. Ferlay et al.
ANNALS OF ONCOLOGY (2007)
P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ
Joana Paredes et al.
VIRCHOWS ARCHIV (2007)
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb et al.
NATURE REVIEWS CANCER (2007)
25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of lα-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer
Eduardo Carneiro de Lyra et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration
WD Huang et al.
SCIENCE (2006)
Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues
GM Zinser et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas
I Matos et al.
VIRCHOWS ARCHIV (2005)
Expression of vitamin D receptor and 25-hydroxyvitamin D3-1α-hydroxylase in normal and malignant human colon
D Matusiak et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Autocrine metabolism of vitamin D in normal and malignant breast tissue
K Townsend et al.
CLINICAL CANCER RESEARCH (2005)
25-hydroxyvitamin D-3 1 alpha-hydroxylase expression in breast cancer and use of non-1 alpha-hydroxylated vitamin D analogue
U Segersten et al.
BREAST CANCER RESEARCH (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice
GM Zinser et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer
M Friedrich et al.
HISTOCHEMICAL JOURNAL (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo
DJ Mantell et al.
CIRCULATION RESEARCH (2000)
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
DG Albertson et al.
NATURE GENETICS (2000)